https://www.selleckchem.com/products/Eloxatin.html
01). A history of KMP and sirolimus treatment were not predictors of lymphedema (P 0.05). Overall, 76.9% of patients received sirolimus treatment after referral, including 53.8% who presented extremity swelling before referral. Seven (53.8%) patients received compression therapy. Five (38.5%) patients reported lymphedema-associated decreased range of motion at the last follow-up. Chronic lymphedema is a common sequela of KHE and can occur independently of KMP and sirolimus treatment. Patients with large and mixed KHE involving ext
Like
Comment
Share
